Cargando…

Cost-effectiveness analysis of alternative colon cancer screening strategies in the context of the French national screening program

BACKGROUND: A nationwide colorectal cancer (CRC) screening program was set up in France from 2009 for average-risk, asymptomatic people aged 50–74 years based on an immunochemical fecal occult blood test [faecal immunochemical test (FIT)] every 2 years, followed by colonoscopy if positive. The Europ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barré, Stéphanie, Leleu, Henri, Benamouzig, R., Saurin, Jean-Christophe, Vimont, Alexandre, Taleb, Sabrine, De Bels, Frédéric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Advances and Future Perspectives in Colorectal Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509710/ https://www.ncbi.nlm.nih.gov/pubmed/33014138 http://dx.doi.org/10.1177/1756284820953364

Ejemplares similares

Cost-effectiveness analysis of alternative colorectal cancer screening strategies in high-risk individuals
por: Benamouzig, Robert, et al.
Publicado: (2021)

Evolution of colorectal cancer screening research in the past 25 years: text-mining analysis of publication trends and topics
por: Soffer, Shelly, et al.
Publicado: (2020)

Alternative chemoradiotherapy in anal carcinoma patients with mutations in thymidylate synthase and dihydropyrimidine dehydrogenase genes
por: Saif, MW, et al.
Publicado: (2021)

A bibliometric analysis of 23,492 publications on rectal cancer by machine learning: basic medical research is needed
por: Wang, Kangtao, et al.
Publicado: (2020)

The association between circulating levels of vitamin D and inflammatory markers in the first 2 years after colorectal cancer diagnosis
por: Wesselink, Evertine, et al.
Publicado: (2020)

Advances in immunotherapy for colorectal cancer: a review
por: Golshani, Gol, et al.
Publicado: (2020)

Insights into the management of anorectal disease in the coronavirus 2019 disease era
por: Amjad, Waseem, et al.
Publicado: (2021)

Update on the role of pembrolizumab in patients with unresectable or metastatic colorectal cancer
por: Wookey, Vanessa, et al.
Publicado: (2021)

Use of CT colonography in the English Bowel Cancer Screening Programme
por: Plumb, Andrew A, et al.
Publicado: (2014)

Colorectal cancer mortality 10 years after a single round of guaiac faecal occult blood test (gFOBT) screening: experiences from a Danish screening cohort
por: Bjerrum, Andreas, et al.
Publicado: (2016)

Use of hospital resources in the Finnish colorectal cancer screening programme: a randomised health services study
por: Mäklin, Suvi, et al.
Publicado: (2015)

Interval colorectal cancers after negative faecal immunochemical test in the New Zealand Bowel Screening Pilot
por: Saw, Kai Sheng, et al.
Publicado: (2023)

Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening
por: Liedenbaum, M H, et al.
Publicado: (2009)

Nimble Approach: fast, adapting, calculating and ethically mindful approach to managing colorectal cancer screening programmes during a pandemic
por: Baxter, Nancy N, et al.
Publicado: (2022)

Colorectal cancer outcomes after screening with the multi-target stool DNA assay: protocol for a large-scale, prospective cohort study (the Voyage study)
por: Olson, Janet E, et al.
Publicado: (2020)

Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre
por: Sapru, Karuna, et al.
Publicado: (2023)

Recommendations for cognitive screening and management in multiple sclerosis care
por: Kalb, Rosalind, et al.
Publicado: (2018)

Organised screening for cervical cancer in France: a cost-effectiveness assessment
por: Barré, Stéphanie, et al.
Publicado: (2017)

Use of ColonFlag score for prioritisation of endoscopy in colorectal cancer
por: Ayling, Ruth M, et al.
Publicado: (2021)

High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer
por: Belt, E. J. Th., et al.
Publicado: (2011)

Adjuvant Therapy for Colon Cancer: Learning from the Past to Inform the Future
por: Sargent, Daniel, et al.
Publicado: (2010)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Preventive effects of Korean red ginseng on experimentally induced colitis and colon carcinogenesis
por: Shin, Hoon-Jeong, et al.
Publicado: (2020)

Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer
por: Veld, Joyce Valerie, et al.
Publicado: (2020)

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
por: Osterman, Erik, et al.
Publicado: (2020)

Locoregionally Recurrent Colon Cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study
por: Swartjes, Hidde, et al.
Publicado: (2022)

Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort
por: Pedrazzani, Corrado, et al.
Publicado: (2022)

Colon Cancer Disparities in Stage at Presentation and Time to Surgery for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study with Disaggregated Ethnic Groups
por: Jain, Bhav, et al.
Publicado: (2023)

Primary Anastomosis Versus End-Ostomy in Left-Sided Colonic and Proximal Rectal Cancer Surgery in the Elderly Dutch Population: A Propensity Score Matched Analysis
por: van Loon, Yu Ting, et al.
Publicado: (2021)

Activated neutrophils induce an hMSH2-dependent G2/M checkpoint arrest and replication errors at a (CA)13-repeat in colon epithelial cells
por: Campregher, C, et al.
Publicado: (2008)

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)
por: Kemeny, M. Margaret, et al.
Publicado: (2022)

Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study
por: Dumont, Frédéric, et al.
Publicado: (2023)

Bevacizumab Efficacy in Metastatic Colorectal Cancer is Dependent on Primary Tumor Resection
por: Ghiringhelli, Francois, et al.
Publicado: (2014)

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition
por: Fujisawa, T, et al.
Publicado: (2008)

Prognostic Value of Resection of Primary Tumor in Patients with Stage IV Colorectal Cancer: Retrospective Analysis of Two Randomized Studies and a Review of the Literature
por: Venderbosch, Sabine, et al.
Publicado: (2011)

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study
por: Lambregts, Doenja M. J., et al.
Publicado: (2011)

K-Ras and MSI: Potential Markers of Both Patient Prognosis and Treatment Efficacy
por: Turaga, Kiran, et al.
Publicado: (2009)

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies
por: Belluco, Claudio, et al.
Publicado: (2011)

Is the 1-cm Rule of Distal Bowel Resection Margin in Rectal Cancer Based on Clinical Evidence? A Systematic Review
por: Bujko, Krzysztof, et al.
Publicado: (2011)

Importance of the First Postoperative Year in the Prognosis of Elderly Colorectal Cancer Patients
por: Dekker, J. W. T., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vjd1hj0oqeh5jbd2cc8795jvu9